Are personalised treatments of adult depression finally within reach?
作者信息
Cuijpers P, Christensen H
机构信息
Department of Clinical, Neuro and Developmental Psychology,Vrije Universiteit Amsterdam,The Netherlands.
Black Dog Institute, University of New South Wales,Randwick, NSW,Australia.
出版信息
Epidemiol Psychiatr Sci. 2017 Feb;26(1):40-42. doi: 10.1017/S204579601600007X. Epub 2016 Mar 11.
Abstract
摘要
相似文献
1
Are personalised treatments of adult depression finally within reach?
Epidemiol Psychiatr Sci. 2017 Feb;26(1):40-42. doi: 10.1017/S204579601600007X. Epub 2016 Mar 11.
2
Targeting treatments for depression: what can our patients tell us?
Epidemiol Psychiatr Sci. 2017 Feb;26(1):37-39. doi: 10.1017/S2045796016000160. Epub 2016 Apr 5.
3
Personalized medicine for depression: can we match patients with treatments?
Am J Psychiatry. 2010 Dec;167(12):1445-55. doi: 10.1176/appi.ajp.2010.09111680. Epub 2010 Sep 15.
4
Symptom-Specific Effects of Psychotherapy versus Combined Therapy in the Treatment of Mild to Moderate Depression: A Network Approach.
Psychother Psychosom. 2018;87(2):121-123. doi: 10.1159/000486793. Epub 2018 Mar 1.
5
Depression: therapy or medication? Therapy and antidepressants may affect the brain differently, but both are effective.
Health News. 2004 Mar;10(3):14-5.
6
Adolescent Depression-Pharmacotherapy or Psychotherapy?
J Dev Behav Pediatr. 2016 Apr;37(3):264. doi: 10.1097/DBP.0000000000000264.
7
[Psychological treatment of depression].
Ugeskr Laeger. 2007 Apr 16;169(16):1444-7.
8
Psychopharmacology plus psychotherapy for depression treatment.
Psychiatr Serv. 2003 Jul;54(7):1042; author reply 1042-3. doi: 10.1176/appi.ps.54.7.1042-a.
9
[The Multidisciplinary Guideline for Depression: a commentary].
Tijdschr Psychiatr. 2006;48(12):921-5.
10
What are the chances for personalised treatment with antidepressants? Detection of patient-by-treatment interaction with a variance ratio meta-analysis.
BMJ Open. 2019 Dec 23;9(12):e034816. doi: 10.1136/bmjopen-2019-034816.
引用本文的文献
1
Personalised & optimised therapy (POT) algorithm using five cognitive and behavioural skills for subthreshold depression.
NPJ Digit Med. 2025 Aug 20;8(1):531. doi: 10.1038/s41746-025-01906-6.
2
Nature-Based Meditation, Rumination and Mental Wellbeing.
Int J Environ Res Public Health. 2022 Jul 26;19(15):9118. doi: 10.3390/ijerph19159118.
3
The Potential for Outdoor Nature-Based Interventions in the Treatment and Prevention of Depression.
Front Psychol. 2022 Mar 23;13:740210. doi: 10.3389/fpsyg.2022.740210. eCollection 2022.
4
Moving beyond a 'one-size-fits-all' rationale in global mental health: prospects of a precision psychology paradigm.
Epidemiol Psychiatr Sci. 2021 Oct 11;30:e63. doi: 10.1017/S2045796021000500.
5
Moderators of intervention efficacy for Finding My Way: A web-based psychosocial intervention for cancer-related distress.
Support Care Cancer. 2021 Dec;29(12):7669-7678. doi: 10.1007/s00520-021-06291-w. Epub 2021 Jun 17.
6
The D*Phase-study: study protocol for a pragmatic two-phased, randomised controlled (non-inferiority) trial that addresses treatment non-response and compares cognitive behavioural therapy and short-term psychodynamic supportive psychotherapy for major depression.
BMC Psychiatry. 2021 May 4;21(1):233. doi: 10.1186/s12888-021-03156-8.
7
Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials.
JAMA Psychiatry. 2021 May 1;78(5):490-497. doi: 10.1001/jamapsychiatry.2020.4564.
8
Redefining Therapeutic Outcomes of Depression Treatment.
J Pers Oriented Res. 2019 Dec 30;5(2):1-8. doi: 10.17505/jpor.2019.10. eCollection 2019.
9
Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials.
JAMA Psychiatry. 2020 Jun 1;77(6):607-617. doi: 10.1001/jamapsychiatry.2019.4815.
10
Personalising psychotherapies for depression using a novel mixed methods approach: an example from Morita therapy.
Trials. 2020 Jan 8;21(1):41. doi: 10.1186/s13063-019-3788-3.
本文引用的文献
1
Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder.
Epidemiol Psychiatr Sci. 2017 Feb;26(1):22-36. doi: 10.1017/S2045796016000020. Epub 2016 Jan 26.
2
The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations. A demonstration.
PLoS One. 2014 Jan 8;9(1):e83875. doi: 10.1371/journal.pone.0083875. eCollection 2014.
3
Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach.
Stat Med. 2013 May 20;32(11):1964-73. doi: 10.1002/sim.5734. Epub 2013 Jan 10.
4
Data-driven subtypes of major depressive disorder: a systematic review.
BMC Med. 2012 Dec 4;10:156. doi: 10.1186/1741-7015-10-156.
5
Personalized treatment of adult depression: medication, psychotherapy, or both? A systematic review.
Depress Anxiety. 2012 Oct;29(10):855-64. doi: 10.1002/da.21985. Epub 2012 Jul 19.
6
Meta-review of depressive subtyping models.
J Affect Disord. 2012 Jul;139(2):126-40. doi: 10.1016/j.jad.2011.07.015. Epub 2011 Sep 1.
7
How can we realize the promise of personalized antidepressant medicines?
Nat Rev Neurosci. 2008 Aug;9(8):638-46. doi: 10.1038/nrn2453. Epub 2008 Jul 16.
8
Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders.
Br J Psychiatry. 2004 Jun;184:526-33. doi: 10.1192/bjp.184.6.526.
Zotero 插件